hi Maxwell, I like to ask you something, we are a biotech that is actually making money, in a market where there is a need, and has not been much progress made in the last 20 years. our product is efficient and safe
we are building a network and some of it is already existing now with maybe 50 hospitals capable of doing the procedure
yet , by the tune of the grapevine talk and chatter, we are currently to the mercy of one disgruntled shareholder who has some sort of influence in the industry to be able to keep the share price where it is and play ball with us.
what do you think has to change to end this?
and also I’m thinking what if this chatter is all but wrong and this is just a strategy to scoop up at the bottom ?
OSL Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)